Table 4.
Indications and contraindications of TAE in patients with NENs
| Indications | Contraindications |
|---|---|
| - NEN tumor functioning or not |
- Massive tumor burden |
| - Highly vascularised liver metastases |
- Severely compromised liver function |
| - Liver metastases >3 in number and or >3 cm in size |
- Poor performance status |
| - Sepsis | |
| - Patients with tumor mass-related symptoms and/or carcinoid syndrome | - Carcinoid heart disease and other risk factors for treatment related mortality |